Richard Schwabacher Named to Modern Healthcare’s Top 25 Emerging Leaders List

ELMWOOD PARK, NJ and Chicago, IL (October 6, 2021) – BioReference Laboratories’ Richard Schwabacher is among Modern Healthcare’s 2021 class of Top 25 Emerging Leaders. Modern Healthcare, the leader in healthcare business news, research and data, annually honors emerging leaders all age 40 or under, who have made significant contributions in the areas of innovation and financial, operational and clinical excellence early in their careers.

“The roller-coaster ride of the COVID-19 pandemic—now more than 18 months long and counting—has tested leaders in all sectors of the healthcare industry and at all levels. The men and women who make up this year’s class of the Top 25 Emerging Leaders have certainly risen to the challenges. Even in their young careers, many have impressive track records of innovation and accomplishment predating the pandemic,” noted Modern Healthcare editor, Aurora Aguilar.

“The profiles of this year’s honorees, all age 40 or under, display the breadth of diversity and talent in this generation of healthcare leadership. Congratulations to all.”

“When Richard joined BioReference, he assumed responsibility for developing and implementing digital strategies through Customer Digital Solutions, Direct-to-Consumer Solutions, Telehealth and Patient Empowerment as SVP, Digital Health and Chief Digital Officer. “Richard is unique in his clear ability to motivate and inspire the people that he leads while earning their respect, teaching them ways to grow, and actively supporting the trajectory of their careers.”

This year’s honorees are profiled in the October 4 issue of MH magazine and online at   

About BioReference Laboratories, Inc.

BioReference Laboratories, Inc., is one of the largest full service specialty laboratories in the United States that gives healthcare providers and patients the power to make confident healthcare decisions. With a focus on genetics, oncology, urology and women’s health, BioReference offers comprehensive test solutions and unparalleled expertise based on a 40 year legacy of proven science. The company is in-network with the largest health plans in the United States, serves approximately 19 million patients annually, operates a network of 11 laboratory locations, and is backed by a medical staff of more than 300 M.D., D.O., Ph.D., genetic counselors and other professional clinical and scientific personnel. With a national footprint and niche market experience, BioReference provides credible and innovative solutions that meet the needs of employers, governmental agencies, educational systems, hospitals and health systems, correctional institutions, sports leagues, travel and leisure industries, and retail markets. BioReference provides industry-leading custom solutions for COVID-19, including point-of-care testing and large-scale screening programs.